Shares of Novacyt SA (LON:NCYT) traded up 11.4% during trading on Monday . The company traded as high as GBX 12 ($0.16) and last traded at GBX 12.25 ($0.16), 34,674 shares changed hands during mid-day trading. The stock had previously closed at GBX 11 ($0.14).
The company has a market capitalization of $7.12 million and a price-to-earnings ratio of -0.47. The company has a current ratio of 0.83, a quick ratio of 0.37 and a debt-to-equity ratio of 47.02. The business’s 50 day moving average price is GBX 8.37 and its two-hundred day moving average price is GBX 9.03.
About Novacyt (LON:NCYT)
Novacyt SA develops and sells diagnostic products for cancer and infectious diseases. The company's diagnostic products are used in liquid based cytology, oncology, microbiology, haematology, and serology testing. It offers NovaPrep, a liquid based cytology solution that is utilized in the diagnosis of cervical cancer; and clinical laboratory testing services to clinicians, healthcare providers, and patients.
Recommended Story: Operating Income
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.